• Je něco špatně v tomto záznamu ?

In Vivo Secretion of β-Lactamase-Carrying Outer Membrane Vesicles as a Mechanism of β-Lactam Therapy Failure

M. Bielaszewska, O. Daniel, O. Nyč, A. Mellmann

. 2021 ; 11 (11) : . [pub] 20211023

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22001476

Grantová podpora
194468054 - SFB 1009, B04 Deutsche Forschungsgemeinschaft (DFG)
NIPH 75010330 Ministry of Health

Outer membrane vesicles carrying β-lactamase (βLOMVs) protect bacteria against β-lactam antibiotics under experimental conditions, but their protective role during a patient's treatment leading to the therapy failure is unknown. We investigated the role of βLOMVs in amoxicillin therapy failure in a patient with group A Streptococcus pyogenes (GAS) pharyngotonsillitis. The patient's throat culture was examined by standard microbiological procedures. Bacterial vesicles were analyzed for β-lactamase by immunoblot and the nitrocefin assay, and in vivo secretion of βLOMVs was detected by electron microscopy. These analyses demonstrated that the patient's throat culture grew, besides amoxicillin-susceptible GAS, an amoxicillin-resistant nontypeable Haemophilus influenzae (NTHi), which secreted βLOMVs. Secretion and β-lactamase activity of NTHi βLOMVs were induced by amoxicillin concentrations reached in the tonsils during therapy. The presence of NTHi βLOMVs significantly increased the minimal inhibitory concentration of amoxicillin for GAS and thereby protected GAS against bactericidal concentrations of amoxicillin. NTHi βLOMVs were identified in the patient's pharyngotonsillar swabs and saliva, demonstrating their secretion in vivo at the site of infection. We conclude that the pathogen protection via βLOMVs secreted by the flora colonizing the infection site represents a yet underestimated mechanism of β-lactam therapy failure that warrants attention in clinical studies.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22001476
003      
CZ-PrNML
005      
20220112153614.0
007      
ta
008      
220107s2021 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/membranes11110806 $2 doi
035    __
$a (PubMed)34832035
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Bielaszewska, Martina $u Centre for Epidemiology and Microbiology, National Institute of Public Health, 100 00 Prague, Czech Republic
245    10
$a In Vivo Secretion of β-Lactamase-Carrying Outer Membrane Vesicles as a Mechanism of β-Lactam Therapy Failure / $c M. Bielaszewska, O. Daniel, O. Nyč, A. Mellmann
520    9_
$a Outer membrane vesicles carrying β-lactamase (βLOMVs) protect bacteria against β-lactam antibiotics under experimental conditions, but their protective role during a patient's treatment leading to the therapy failure is unknown. We investigated the role of βLOMVs in amoxicillin therapy failure in a patient with group A Streptococcus pyogenes (GAS) pharyngotonsillitis. The patient's throat culture was examined by standard microbiological procedures. Bacterial vesicles were analyzed for β-lactamase by immunoblot and the nitrocefin assay, and in vivo secretion of βLOMVs was detected by electron microscopy. These analyses demonstrated that the patient's throat culture grew, besides amoxicillin-susceptible GAS, an amoxicillin-resistant nontypeable Haemophilus influenzae (NTHi), which secreted βLOMVs. Secretion and β-lactamase activity of NTHi βLOMVs were induced by amoxicillin concentrations reached in the tonsils during therapy. The presence of NTHi βLOMVs significantly increased the minimal inhibitory concentration of amoxicillin for GAS and thereby protected GAS against bactericidal concentrations of amoxicillin. NTHi βLOMVs were identified in the patient's pharyngotonsillar swabs and saliva, demonstrating their secretion in vivo at the site of infection. We conclude that the pathogen protection via βLOMVs secreted by the flora colonizing the infection site represents a yet underestimated mechanism of β-lactam therapy failure that warrants attention in clinical studies.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Daniel, Ondřej $u Centre for Epidemiology and Microbiology, National Institute of Public Health, 100 00 Prague, Czech Republic $u Second Medical Faculty, Charles University, 150 06 Prague, Czech Republic
700    1_
$a Nyč, Otakar $u Institute of Medical Microbiology, University Hospital Motol, 150 06 Prague, Czech Republic
700    1_
$a Mellmann, Alexander $u Institute for Hygiene, University Hospital Münster, 48149 Münster, Germany
773    0_
$w MED00207608 $t Membranes $x 2077-0375 $g Roč. 11, č. 11 (2021)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34832035 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20220107 $b ABA008
991    __
$a 20220112153610 $b ABA008
999    __
$a ind $b bmc $g 1745493 $s 1152623
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 11 $c 11 $e 20211023 $i 2077-0375 $m Membranes $n Membranes (Basel) $x MED00207608
GRA    __
$a 194468054 - SFB 1009, B04 $p Deutsche Forschungsgemeinschaft (DFG)
GRA    __
$a NIPH 75010330 $p Ministry of Health
LZP    __
$a Pubmed-20220107

Najít záznam

Citační ukazatele

Možnosti archivace